Skip to content
Loop Biz – Lifestyle
Author:
Quetzal Therapeutics
Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia
June 11, 2026